X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9542) 9542
Publication (788) 788
Newsletter (244) 244
Book Review (102) 102
Newspaper Article (27) 27
Book Chapter (13) 13
Dissertation (11) 11
Magazine Article (9) 9
Transcript (4) 4
Conference Proceeding (3) 3
Book / eBook (1) 1
Paper (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
docetaxel (8913) 8913
humans (7286) 7286
oncology (5918) 5918
index medicus (5318) 5318
female (4617) 4617
chemotherapy (4484) 4484
middle aged (4193) 4193
male (4132) 4132
aged (3931) 3931
cancer (3373) 3373
antineoplastic combined chemotherapy protocols - therapeutic use (3200) 3200
adult (2968) 2968
taxoids - administration & dosage (2791) 2791
treatment outcome (2428) 2428
paclitaxel (2062) 2062
care and treatment (1747) 1747
breast neoplasms - drug therapy (1701) 1701
antineoplastic combined chemotherapy protocols - adverse effects (1581) 1581
breast cancer (1580) 1580
pharmacology & pharmacy (1563) 1563
cisplatin (1501) 1501
therapy (1395) 1395
prostate cancer (1377) 1377
lung neoplasms - drug therapy (1362) 1362
metastasis (1338) 1338
research (1319) 1319
trial (1306) 1306
aged, 80 and over (1295) 1295
carcinoma, non-small-cell lung - drug therapy (1202) 1202
medicine & public health (1185) 1185
antineoplastic agents - therapeutic use (1150) 1150
neoplasm staging (1147) 1147
disease-free survival (1129) 1129
drug therapy (1122) 1122
survival (1112) 1112
drug administration schedule (1093) 1093
paclitaxel - administration & dosage (1082) 1082
animals (1051) 1051
taxoids - adverse effects (1003) 1003
breast neoplasms - pathology (994) 994
analysis (976) 976
antineoplastic agents - administration & dosage (970) 970
taxoids - therapeutic use (967) 967
cisplatin - administration & dosage (954) 954
clinical trials (921) 921
antineoplastic agents (912) 912
survival analysis (884) 884
survival rate (874) 874
antineoplastic combined chemotherapy protocols - administration & dosage (851) 851
doxorubicin (847) 847
antimitotic agents (839) 839
prognosis (836) 836
combination (833) 833
carcinoma (830) 830
prostatic neoplasms - drug therapy (823) 823
neoplasm metastasis (807) 807
gemcitabine (805) 805
cancer therapies (777) 777
dosage and administration (774) 774
deoxycytidine - analogs & derivatives (772) 772
hematology, oncology and palliative medicine (769) 769
retrospective studies (762) 762
phase-ii trial (748) 748
lung neoplasms - pathology (737) 737
fluorouracil - administration & dosage (728) 728
lung cancer (728) 728
lung cancer, non-small cell (715) 715
health aspects (708) 708
tumors (702) 702
dose-response relationship, drug (677) 677
deoxycytidine - administration & dosage (675) 675
carboplatin (667) 667
cell line, tumor (659) 659
taxoids (650) 650
carcinoma, non-small-cell lung - pathology (634) 634
fluorouracil (624) 624
mice (616) 616
patients (606) 606
antineoplastic agents - adverse effects (601) 601
disease progression (600) 600
urology & nephrology (600) 600
toxicity (591) 591
paclitaxel - analogs & derivatives (588) 588
phase-iii trial (586) 586
phase-ii (579) 579
cancer research (577) 577
oncology, experimental (569) 569
mitoxantrone (553) 553
adenocarcinoma - drug therapy (552) 552
radiotherapy (543) 543
non-small cell lung cancer (541) 541
pharmacology/toxicology (539) 539
randomized-trial (527) 527
pharmacokinetics (522) 522
nanoparticles (521) 521
trastuzumab (520) 520
cell lung-cancer (518) 518
cyclophosphamide (513) 513
prednisone (506) 506
respiratory system (505) 505
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9680) 9680
French (49) 49
German (40) 40
Japanese (30) 30
Korean (14) 14
Chinese (12) 12
Spanish (6) 6
Russian (4) 4
Italian (3) 3
Polish (2) 2
Dutch (1) 1
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD004064 - CD004064
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Summary Background Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2008, Volume 100, Issue 2, pp. 121 - 133
Background Docetaxel is more effective than doxorubicin for patients with advanced breast cancer. The Breast International Group 02-98 randomized trial tested... 
CANCER PATIENTS | 1ST-LINE TREATMENT | PHASE-II TRIAL | THERAPY | EPIRUBICIN | ONCOLOGY | DOXORUBICIN PLUS CYCLOPHOSPHAMIDE | METHOTREXATE | COMBINATION CHEMOTHERAPY | FLUOROURACIL | CMF | Immunohistochemistry | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Mastectomy - methods | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Tamoxifen - administration & dosage | Receptors, Progesterone - analysis | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Odds Ratio | Adenocarcinoma - chemistry | Doxorubicin - administration & dosage | Drug Administration Schedule | Estrogen Receptor Modulators - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Methotrexate - administration & dosage | Aged | Adenocarcinoma - surgery | Breast cancer | Dosage and administration | Drug therapy | Comparative analysis | Doxorubicin | Docetaxel | Clinical trials | Comparative studies | Chemotherapy | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2012, Volume 158, Issue 3, pp. 470 - 478
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article